27 results
8-K
BTAX
Biostax Corp.
20 Feb 25
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:08pm
the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information
8-K
EX-99.2
BTAX
Biostax Corp.
20 Feb 25
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:08pm
seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition
8-K
EX-99.1
BTAX
Biostax Corp.
2 Nov 23
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
9:00am
for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding
8-K
EX-99.1
xrnjal7dwkk
24 Oct 23
Amendments to Articles of Incorporation or Bylaws
9:00am
8-K
EX-99.1
xma7cn28
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
8-K
EX-99.1
6jcw d4hvf6ov4
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-99.1
7qith6255 rxgdhqw8hl
27 Sep 22
Immune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors
2:37pm
D
6hplpnq6
31 Aug 22
$5M in debt
2:58pm
8-K
EX-99.1
hyeek4gadwdacc
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
8-K
EX-99.1
78lca9ks z8ts3y
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm